Hensin Tsao

Hensin Tsao's AcademicInfluence.com Rankings

Hensin Tsao

Engineering

#6351

World Rank

#7672

Historical Rank

Biomedical Engineering

#560

World Rank

#570

Historical Rank

engineering Degrees

Hensin Tsao

Philosophy

#8640

World Rank

#12054

Historical Rank

Logic

#5665

World Rank

#7082

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

Hensin Tsao's Degrees

Doctorate Medicine Harvard University

Why Is Hensin Tsao Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hensin Tsao's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Management of cutaneous melanoma. (2004) (847)
Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function. (2010) (682)
Melanoma: from mutations to medicine. (2012) (479)
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma. (2004) (449)
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma (2011) (414)
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. (2006) (401)
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents (2006) (384)
A Two-Stage, p16INK4A- and p53-Dependent Keratinocyte Senescence Mechanism That Limits Replicative Potential Independent of Telomere Status (2002) (361)
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling (2007) (353)
Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. (2011) (333)
The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate. (2003) (256)
Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines. (2000) (250)
Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines (1998) (249)
Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants (2007) (244)
Cutaneous melanomas associated with nevi. (2003) (242)
Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families (2012) (235)
Guidelines of care for the management of primary cutaneous melanoma. (2019) (232)
Melanoma genetics and therapeutic approaches in the 21st century: moving from the benchside to the bedside. (2008) (203)
Genetic Alterations in Signaling Pathways in Melanoma (2006) (188)
Selection criteria for genetic assessment of patients with familial melanoma. (2009) (168)
The skin microbiome: current perspectives and future challenges. (2013) (159)
Melanoma: new insights and new therapies. (2012) (154)
Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome. (2016) (146)
Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy (2015) (141)
Ultra‐late recurrence (15 years or longer) of cutaneous melanoma (1997) (137)
Genetics of melanocytic nevi (2015) (135)
Early detection of melanoma: reviewing the ABCDEs. (2015) (134)
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide (2018) (133)
A population‐based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors (2003) (130)
Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants (2013) (121)
PTEN expression in normal skin, acquired melanocytic nevi, and cutaneous melanoma. (2003) (116)
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study (2010) (113)
Introduction to genetic association studies. (2007) (112)
Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma. (2011) (111)
Activation of PI3K Signaling in Merkel Cell Carcinoma (2012) (103)
Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma (2012) (102)
EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma. (2015) (102)
Somatic driver mutations in melanoma (2017) (97)
Gender Disparity and Mutation Burden in Metastatic Melanoma. (2015) (95)
Expression profiling of UVB response in melanocytes identifies a set of p53-target genes. (2006) (95)
An estimate of the annual direct cost of treating cutaneous melanoma. (1998) (91)
The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomas. (2008) (86)
Novel mutations in the p16/CDKN2A binding region of the cyclin-dependent kinase-4 gene. (1998) (86)
Ultraviolet radiation and malignant melanoma. (1998) (86)
Update on the Epidemiology of Melanoma (2013) (86)
Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma. (2000) (86)
A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma (2015) (86)
Association between female breast cancer and cutaneous melanoma (2004) (81)
Melanoma and genetics. (2009) (81)
A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma. (2001) (80)
The state of melanoma: challenges and opportunities (2016) (79)
Epha2 is a Critical Oncogene in Melanoma (2011) (78)
Small RNAs in development and disease. (2008) (78)
Phenotypic and genotypic analyses of genetic skin disease through the Online Mendelian Inheritance in Man (OMIM) database. (2009) (77)
Update on familial cancer syndromes and the skin. (2000) (76)
The genetics of skin cancer (2004) (76)
p53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibition. (2012) (75)
Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype. (2015) (75)
Targeting the RAS pathway in melanoma. (2012) (72)
MITF Modulates Therapeutic Resistance through EGFR Signaling (2015) (72)
Recurrent patterns of dual RB and p53 pathway inactivation in melanoma. (2005) (71)
Spitz nevi and other Spitzoid lesions part I. Background and diagnoses. (2011) (71)
Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature (2017) (71)
Outcome of patients with de novo versus nevus-associated melanoma. (2015) (67)
Failure of Q-switched ruby laser to eradicate atypical-appearing solar lentigo: report of two cases. (1998) (63)
Mutational and expression analysis of the p73 gene in melanoma cell lines. (1999) (61)
Long-term outcome of Spitz-type melanocytic tumors. (2011) (59)
Evidence for an association between cutaneous melanoma and non‐Hodgkin lymphoma (2001) (59)
CRM1 and BRAF Inhibition Synergize and Induce Tumor Regression in BRAF-Mutant Melanoma (2013) (58)
Hereditary nonmelanoma skin cancer. (2012) (58)
Sentinel lymph node metastasis is not predictive of poor outcome in patients with problematic spitzoid melanocytic tumors. (2013) (58)
Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival. (2016) (57)
Hereditary melanoma: Update on syndromes and management: Emerging melanoma cancer complexes and genetic counseling. (2016) (56)
Spitz nevi and other Spitzoid lesions part II. Natural history and management. (2011) (56)
X-chromosome inactivation and skin disease. (2008) (52)
Early detection of asymptomatic pulmonary melanoma metastases by routine chest radiographs is not associated with improved survival. (2004) (52)
Genetic Interaction Between NRAS and BRAF Mutations and PTEN / MMAC 1 Inactivation in Melanoma (2010) (51)
Genetics of nonmelanoma skin cancer. (2001) (49)
Cutaneous melanoma in women☆☆☆ (2015) (48)
The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma. (2019) (48)
Combined use of intense pulsed light and Q‐switched ruby laser for complex dyspigmentation among asian patients (2008) (48)
Estimating CDKN2A carrier probability and personalizing cancer risk assessments in hereditary melanoma using MelaPRO. (2010) (47)
Genetics of melanoma tumorigenesis (2007) (47)
EphA2 is an essential mediator of UV radiation-induced apoptosis. (2008) (47)
Loss of xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice. (2007) (47)
Acquired bilateral nevus of Ota-like macules (Hori nevus): etiologic and therapeutic considerations. (2009) (45)
Histologically challenging melanocytic tumors referred to a tertiary care pigmented lesion clinic. (2012) (45)
Melanoma: clinical features and genomic insights. (2014) (42)
Melanoma susceptibility genes and risk assessment. (2014) (42)
Hypopigmentation associated with an adenovirus-mediated gp100/MART-1-transduced dendritic cell vaccine for metastatic melanoma. (2002) (41)
New insights into pigmentary pathways and skin cancer (2010) (41)
High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma. (2018) (41)
KIT and Melanoma: Biological Insights and Clinical Implications (2020) (41)
Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. (1996) (41)
Burden of unique and low prevalence somatic mutations correlates with cancer survival (2019) (39)
Dermal melanocytic proliferation with features of a plaque-type blue nevus and neurocristic hamartoma. (2003) (39)
Vemurafenib Synergizes with Nutlin-3 to Deplete Survivin and Suppresses Melanoma Viability and Tumor Growth (2013) (38)
Genetic testing in hereditary melanoma. (2004) (38)
The first 30 years of the American Academy of Dermatology skin cancer screening program: 1985‐2014 (2018) (38)
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL). (2008) (37)
Lesions resembling malignant atrophic papulosis in a patient with dermatomyositis. (1997) (36)
Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma (2011) (36)
MELPREDICT: a logistic regression model to estimate CDKN2A carrier probability (2005) (36)
Cell-selective inhibition of NF-κB signaling improves therapeutic index in a melanoma chemotherapy model. (2011) (35)
Melanoma treatment update. (2005) (35)
Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma. (2000) (35)
Desmoplastic neurotropic melanoma. (1997) (35)
Melanoma genetics: an update on risk-associated genes. (2009) (34)
In vivo coherent Raman imaging of the melanomagenesis-associated pigment pheomelanin (2016) (33)
BRCA1‐associated protein (BAP1)‐inactivated melanocytic tumors (2019) (31)
Genetic determinants of cutaneous melanoma predisposition. (2010) (31)
BAP1 PLAYS A SURVIVAL ROLE IN CUTANEOUS MELANOMA (2014) (31)
A reliable skin mole localization scheme (2007) (31)
The utility of re-excising mildly and moderately dysplastic nevi: a retrospective analysis. (2014) (30)
Pigmented purpuric eruption associated with injection medroxyprogesterone acetate. (2000) (28)
Pathways to melanoma. (2010) (28)
Molecular therapeutic approaches to melanoma. (2010) (28)
Elevation of thyroid cancer risk among cutaneous melanoma survivors (2006) (26)
A Two-Stage, p16INK4A- and p53-Dependent Keratinocyte Senescence Mechanism That Limits Replicative Potential Independent of Telomere Status (2002) (25)
Melanocytes Are Selectively Vulnerable to UVA-mediated Bystander Oxidative Signaling (2013) (25)
Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing (2017) (24)
Epidermal, sebaceous, and melanocytic nevoid proliferations are spectrums of mosaic RASopathies. (2014) (24)
Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation. (2015) (23)
Genetics of melanoma predisposition (2008) (23)
Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients. (2017) (23)
Cutaneous melanoma: family screening and genetic testing (2006) (22)
Contrasting features of childhood and adolescent melanomas (2018) (21)
The Distribution of Microscopic Melanoma Metastases in Sentinel Lymph Nodes: Implications for Pathology Protocols (2012) (21)
Hypoxia and HIF-1α Regulate Collagen Production in Keloids. (2020) (20)
Use of Targeted Next-Generation Sequencing to Identify Activating Hot Spot Mutations in Cherry Angiomas (2019) (19)
Current status and future directions of molecularly targeted therapies and immunotherapies for melanoma. (2014) (19)
The State of Melanoma: Emergent Challenges and Opportunities (2021) (18)
Lack of phospholipase A2 mutations in neuroblastoma, melanoma and colon‐cancer cell lines (1997) (18)
Clinical spectrum of cutaneous melanoma morphology (2019) (17)
Visual Inspection and the US Preventive Services Task Force Recommendation on Skin Cancer Screening. (2016) (17)
DNASE1 and Systemic Lupus Erythematosus (2001) (17)
Classifying melanoma by TERT promoter mutational status. (2020) (16)
Genodermatoses with cutaneous tumors and internal malignancies. (2008) (16)
Identification and mutation analysis of DOC-1R, a DOC-1 growth suppressor-related gene. (1999) (16)
Hereditary cancer syndromes of the skin. (2005) (14)
Targeted therapies in melanoma: Translational research at its finest (2015) (14)
A single-institution case series of patients with cutaneous melanoma and non-Hodgkin's lymphoma. (2002) (14)
Chronic varicella zoster infection mimicking a basal cell carcinoma in an AIDS patient. (1997) (14)
Melanoma genetics: the other side. (2013) (14)
Recent Advances in Melanoma and Melanocyte Biology. (2017) (13)
The M53I mutation in CDKN2A is a founder mutation that predominates in melanoma patients with Scottish ancestry (2007) (13)
Abstract 958: Treatment with a selective inhibitor of BRAFV600E increases melanocyte antigen expression and CD8 T cell infiltrate in tumors of patients with metastatic melanoma (2011) (13)
Urgent access to a specialty care melanoma clinic is associated with a higher rate of melanoma detection. (2011) (13)
The genomics issue (2001) (12)
Effect of the COVID-19 Pandemic on Delayed Skin Cancer Services (2021) (12)
A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds. (2011) (12)
Selective uveal melanoma inhibition with calcium channel blockade (2019) (11)
Activation of PI 3 K Signaling in Merkel Cell Carcinoma (2012) (11)
Moderate- to low-risk variant alleles of cutaneous malignancies and nevi: lessons from genome-wide association studies (2009) (10)
The RAS/mitogen activated protein (MAP) kinase pathway in melanoma biology and therapeutics (2007) (10)
Growth suppression by dual BRAF(V600E) and NRAS(Q61) oncogene expression is mediated by SPRY4 in melanoma (2019) (10)
Defining Clonal Color in Fluorescent Multi-Clonal Tracking (2016) (10)
Clinical and therapeutic implications of melanoma genomics (2018) (10)
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia (2021) (10)
How cutaneous eruptions help to understand the mode of action of kinase inhibitors (2012) (10)
Agminated segmental nevi demonstrating intranevic concordance of BRAF status. (2011) (9)
Cancer risks associated with the germline MITF(E318K) variant (2020) (9)
A Case of Nivolumab-Induced Cutaneous Toxicity with Multiple Morphologies (2020) (9)
A novel methionine-53-valine mutation of p16 in a hereditary melanoma kindred. (2004) (9)
Germline CDKN2A mutations among Greek patients with early-onset and multiple primary cutaneous melanoma. (2006) (9)
Surgical delay and mortality for primary cutaneous melanoma (2020) (8)
Immunology of Human Melanoma (1997) (8)
Phenotypic categorization of genetic skin diseases reveals new relations between phenotypes, genes and pathways (2009) (7)
Clinical significance of microscopic melanoma metastases in the nonhottest sentinel lymph nodes. (2015) (7)
Genetics for the practicing dermatologist. (2010) (7)
Loss of ACK1 Upregulates EGFR and Mediates Resistance to BRAF inhibition. (2020) (7)
A novel multi-CDK inhibitor P1446A-05 restricts melanoma growth and produces synergistic effects in combination with MAPK pathway inhibitors (2016) (7)
Melanoma genomics: a state‐of‐the‐art review of practical clinical applications * (2021) (6)
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-2004. A 48-year-old woman with multiple pigmented lesions and a personal and family history of melanoma. (2004) (6)
Primer on the human genome. (2007) (6)
Recent Updates on Genetics: Teaching Old Dogmas New Tricks (2008) (5)
Factors associated with suspected nonmelanoma skin cancers, dysplastic nevus, and cutaneous melanoma among first-time SPOTme screening program participants (2009-2010). (2018) (5)
New Insights into the Molecular Distinction of Dysplastic Nevi and Common Melanocytic Nevi-Highlighting the Keratinocyte-Melanocyte Relationship. (2016) (5)
Immunotherapeutic strategies for cutaneous squamous cell carcinoma prevention in xeroderma pigmentosum (2019) (5)
CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters (2018) (5)
Cutaneous Presentation of Mesothelioma With a Sarcomatoid Transformation. (2017) (5)
Beta‐catenin causes fibrotic changes in the extracellular matrix via upregulation of collagen I transcription (2017) (4)
Commentary: Molecular testing in melanoma. (2014) (4)
Commentary: American Academy of Dermatology free skin cancer screening: 30 years of value. (2017) (4)
Patient-identified early clinical warning signs of nodular melanoma: a qualitative study (2021) (4)
The Burden of Nonmelanoma Skin Cancer (2015) (4)
Dusting for Fingerprints (2004) (3)
Case–control analysis identifies shared properties of rare germline variation in cancer predisposing genes (2019) (3)
Melanoma classification and management in the era of molecular medicine. (2022) (3)
Aggressive Skull Base Metastasis from Uveal Melanoma: A Clinicopathologic Study (2014) (3)
The SNPs of RAF. (2005) (3)
FROM THE ACADEMY Guidelines of care for the management of primary cutaneous melanoma (2011) (3)
DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype (2022) (3)
The Pigmentary System. Second edition (2007) (3)
Cutaneous melanoma in women (2015) (3)
Consensus, Controversy, and Conversations About Gene Expression Profiling in Melanoma. (2020) (3)
‘Benchside‐to‐Bedside’ (2007) (3)
The molecular context of vulnerability for CDK9 suppression in triple wild-type melanoma. (2021) (3)
Images in clinical medicine. Keratoacanthoma. (1999) (2)
Case–control analysis identifies shared properties of rare germline variation in cancer predisposing genes (2018) (2)
Piecing Together p53 (2008) (2)
Iconography : Guidelines of care for the management of primary cutaneous melanoma (2018) (2)
Genetics of Non-Melanoma Skin Cancers and Associated Familial Syndromes (2010) (2)
Epidemiology of Melanoma (2017) (2)
Recognition, Staging, and Management of Melanoma. (2021) (2)
Dynamic gene expression analysis links melanocyte growth arrest with nevogenesis. (2009) (2)
Oncogene-directed small molecule inhibitors for the treatment of cutaneous melanoma. (2015) (2)
A Strategy for Large-Scale Systematic Pan-Cancer Germline Rare Variation Analysis (2017) (1)
Abstracts of the 6th Congress of the European Association of Dermatologic Oncology 16–19 June 2010, Athens, Greece (2010) (1)
A Symmetric Eczematous Eruption Harboring Thousands of Melanocytic Lesions. (2016) (1)
Abstract 1970: Inhibition of BRAF-V600E increases melanocyte antigen expression and antigen-specific recognition in melanoma without altering T cell function (2010) (1)
Sentinel Lymph Node Biopsy versus Nodal Observation in Melanoma (2014) (1)
Guidelines for the Management of Primary Cutaneous Melanoma (2011) (1)
Abstract 1610: MAPK inhibitor resistance leads to ligand-independent Ephrin A2 receptor signaling and the formation of new melanoma metastases (2014) (1)
A Loss-of-Function Variant Related to Telomere Maintenance May Predispose to Familial Melanoma (2014) (1)
Abstract LB-307: Dissecting mutual exclusiveness of oncogenic mutations in melanoma (2017) (1)
Number needed to screen (NNS) for presumptive screening diagnoses among first-time SPOTme screening participants (1992-2010). (2020) (1)
Unsupervised Phenotype-Based Clustering of Clinicopathologic Features in Cutaneous Melanoma (2021) (1)
Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing. (2023) (1)
The spectrum of morphologic patterns of nodular melanoma: a study of the International Dermoscopy Society (2021) (1)
Acquired Precursor Lesions and Phenotypic Markers of Increased Risk for Cutaneous Melanoma (2018) (1)
Oncogenic KIT Induces Replication stress and Confers Cell Cycle Checkpoint Vulnerability in Melanoma. (2021) (1)
Familial Atypical Multiple Mole Melanoma Syndrome (2020) (1)
Abstract A157: Double‐targeted therapy against melanoma: p53 activation sensitizes melanoma cells to MEK inhibition (2009) (1)
Mutational analysis of the CDK-4 gene in human pancreatic endocrine tumors (2000) (1)
Melanoma Genetics and Genomics (2011) (1)
Melanoma‐associated naevi: precursors or coincidence? (2015) (1)
Reply to: "time to move forward after the report of the AAD Task Force for the ABCDEs of Melanoma". (2015) (1)
Cutting It Close (2010) (1)
The T Cell Strikes Back (2013) (0)
Parkinson Disease and Increased Melanoma Risk (2010) (0)
Transforming Marfan Treatment (2006) (0)
Lessons from Blister Juice (2009) (0)
15881 Number-needed-to-treat analysis of skin cancers among referrals for suspicious lesions (2020) (0)
Tumor-Infiltrating Lymphocytes Predict SLN Status and Prognosis in Melanoma (2012) (0)
Anti-PD-1 Continues to Show Benefit in Melanoma (2014) (0)
Histones and Melanoma (2011) (0)
A Mole Gene Among Us (2009) (0)
Utility or Futility — Chest X-Rays for Melanoma Surveillance (2010) (0)
Are Melanocytic Nevi Biomarkers of Breast Cancer Risk (2014) (0)
Patch-y Mutational Profile (2013) (0)
Defect Discovered in Dowling-Degos Disease (2006) (0)
Dermatology Top Stories of 2012 (2012) (0)
Heavy Metal in Melanoma (2009) (0)
Improving Aging with Lipid-Lowering Drugs (2006) (0)
Novel Imaging-based Biomarkers for Melanoma Diagnosis Using Coherent Raman Scattering Microscopy (2016) (0)
Getting under the skin of melanoma (2002) (0)
Fine MAPping in Melanoma (2012) (0)
Epidermodysplasia Verruciformis Made EVER More Clear (2003) (0)
217 Time-to-event machine learning prediction of metastatic recurrence of localized melanoma (2023) (0)
Lichen It to Lipoid Proteinosis (2003) (0)
New Treatment for Kaposi Sarcoma (2004) (0)
Through Thick and Thin: Should We Rethink Thickness and Prognosis? (2014) (0)
Genetic Supervision of Melanoma by (2006) (0)
TIL'ing Immunotherapy (2012) (0)
Melanoma and Organ Transplants (2015) (0)
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy. (2023) (0)
Mutation to Medicine: Improved Survival with Vemurafenib in Melanoma (2011) (0)
BRAF and Melanoma (2002) (0)
Fishing for New Pigment Genes (2006) (0)
Tumors May Be Associated with Worse Outcomes (2011) (0)
The BOS MAN Cometh (2004) (0)
Vemurafenib and Uveitis (2014) (0)
DFSP: Meds vs. Mohs (2005) (0)
Moles and Genes (2015) (0)
Personalizing melanoma medicine in the molecular era (2010) (0)
Keeping an Eye on Ocular Melanoma (2009) (0)
BRAF and Melanoma: Taking It Personally (2010) (0)
Opening the melanoma black box (2014) (0)
Tracing Nevus Evolution (2015) (0)
Molecular Markers in Melanoma: RT-PCR or RT-DNR? (2003) (0)
Potential Independent of Telomere Status Mechanism That Limits Replicative p53-Dependent Keratinocyte Senescence - and INK4A A Two-Stage, p16 (2014) (0)
Melanoma medicine in the new millennium (2021) (0)
The Hand-Held Dermatologist (2013) (0)
NEJM Journal Watch Dermatology Top Stories of 2014 (2014) (0)
A Herpes-Simplex-Virus Derivative Produced Relatively Durable Response in Tumors of Advanced Melanoma (2015) (0)
New Facts About Fat (2008) (0)
COX2 Inhibition and Nonmelanoma Skin Cancer (2010) (0)
215 Cutaneous immune-related adverse events predict longer patient survival in advanced cancer patients (2022) (0)
American Academy of Dermatology 1999 Awards for Young Investigators in Dermatology. Targets of genetic injury in cutaneous melanoma. (1999) (0)
Sun Protection and Survivors (2013) (0)
Better-Than-Expected: A Review Finds Relatively Better Survival in Melanoma of Unknown Primary (2015) (0)
And the Hits Keep Coming (2012) (0)
Lip and Tip SNPs (2010) (0)
Adverse Effects of Cosmetic Procedures (2014) (0)
Non-Melanoma Skin Cancers and Hereditary Cancer Syndromes (2011) (0)
AIM HIGH Hits Low (2003) (0)
NEJM Journal Watch Dermatology Top Stories of 2015 (2015) (0)
Polymorphism and Melanoma Risk (2002) (0)
Tenascin-X and Autosomal Recessive Ehlers-Danlos Syndrome (2001) (0)
Abstract A33: EphA2 Receptor: Evidence for a proto-oncogenic role in melanoma (2009) (0)
A Spitz Probe on 9p21 (2013) (0)
Melanoma Signatures Come of Age (2006) (0)
726 Role of β-catenin in collagen I production in keloid pathogenesis (2016) (0)
Hair-Raising and Nerve-Racking Stem Cells (2006) (0)
Interesting Results from Genomic Classification of Cutaneous Melanomas (2015) (0)
Dissecting BCC Risk (2009) (0)
Combined Immune Checkpoint Therapies Impressive in Advanced Melanoma (2013) (0)
Start SPRED-ing the News: A Neurofibromatosis-like Disorder (2007) (0)
Introduction to JID's Landmarks in the Molecular Revolution. (2017) (0)
Collagen and Cancer (2005) (0)
P045. The MelGene database: A field synopsis of genetic association studies in cutaneous melanoma (2011) (0)
705 Cyclin-dependent kinase 9 (CDK9) as a therapeutic target in uveal and triple-wild type melanoma (2019) (0)
Pulsing Vemurafenib May Avoid Effects of Drug Resistance (2013) (0)
Nivolumab and Melanoma (2014) (0)
The Prognosis for Sentinel Lymph Node Biopsies (2006) (0)
Mutations and Epimutations (2007) (0)
More Is More: Two New Studies Identify Gene Mutations in Melanoma (2012) (0)
Molecular Epidemiology of Melanoma (2018) (0)
The Melanoma Stem Cell Controversy Continues (2010) (0)
Regression and Sentinel Lymph Node Positivity (2016) (0)
Battle of the Bulge (2004) (0)
KIT’ing Around (2009) (0)
235 Distinct biological pathways associated with individual stages of tumor progression in KIT-altered melanoma (2023) (0)
B3 to the Rescue (2015) (0)
Ding-Dong, the Itch Is Dead (2007) (0)
Melanoma of Unknown Prognosis (2014) (0)
Identification of the Harlequin Ichthyosis Gene -- Easy as ABC (2005) (0)
Refsum Disease Becomes Per-PEX'ing (2003) (0)
638 Inverse genetic risk between cutaneous melanoma, basal cell carcinoma, squamous cell carcinoma and vitiligo (2022) (0)
Hairs and Hairpins: A Novel Role for the Telomere (2005) (0)
Dermoscopic Evaluation of Nodular Melanoma (2013) (0)
Men, Melanoma, and Mortality (2014) (0)
A Geographically-Based Cross-Sectional Analysis of SPOT me® Skin Cancer Screening Data. (2020) (0)
Seeing the Light in Ocular Melanoma (2010) (0)
Keratinocytic skin cancers—Update on the molecular biology (2023) (0)
Dermatology Editors' Choice: Top Stories of 2013 (2013) (0)
Finally, Evidence That Sunscreen Delivers (2011) (0)
Abstract 5030: Mechanistic insight of differential sensitivity to MEK inhibition (2010) (0)
Vemurafenib for Previously Treated Melanomas (2012) (0)
Size Does Matter: Telomere Length and Melanoma Risk (2014) (0)
Cancer Therapy : Preclinical Vemurafenib SynergizeswithNutlin-3 toDeplete Survivin and Suppresses Melanoma Viability and Tumor Growth (2013) (0)
Unraveling Spitz Tumors (2014) (0)
104 The molecular context of vulnerability for CDK9 suppression in melanoma (2020) (0)
Something New, Something Old: Adding Vaccine to Interleukin-2 for Advanced Melanoma Improves Response (2011) (0)
Linking Interferon Response with Autoimmunity (2006) (0)
What Is the Optimal Frequency of Postmelanoma Follow-Up? (2012) (0)
369 Comparison of childhood and adolescent melanoma (2017) (0)
Capturing the Elusive LEOPARD (2003) (0)
Translational Medicine for Overcoming Drug-Resistant Tumors (2014) (0)
Endurance of Survival Benefit with Ipilimumab Therapy for Advanced Melanoma (2015) (0)
Concerns About Presence of a Wild-Type BAP1 Allele in Absence of Nuclear Protein Expression-Reply. (2015) (0)
The Long, Happy Life of the Halo Nevus (2012) (0)
The Role of BRAFV600E Mutation in the Development of Nevi (2013) (0)
Case records of the Massachusetts General Hospital. Case 30-2010. A 15-year-old boy with a recurrent skin lesion. (2010) (0)
Update on immune checkpoint therapy for melanoma (2022) (0)
Pembrolizumab and Nivolumab vs. Ipilimumab in Advanced Melanoma (2015) (0)
The Rise and Fall of German Melanoma Rates (2015) (0)
Technical Knockdown in Melanoma (2006) (0)
Marginal Return: Safe and Sufficient Margins for Thick Melanoma (2011) (0)
Less Is More — Number Needed to Excise Decreased as Accurate Melanoma Diagnosis Increased (2011) (0)
Epithelioid Sarcoma Presenting as a Benign Foot Ulcer (1997) (0)
UV Inflammation and Melanoma (2014) (0)
Keeping a Blue Eye on (2007) (0)
Burden of unique and low prevalence somatic mutations correlates with cancer survival (2019) (0)
Better Together: Combining BRAF and MEK Inhibitors Prolonged Progression-Free Survival in Metastatic Melanoma (2012) (0)
The Root of the Alopecia Areata Problem (2010) (0)
Abstract 5605: Pharmacologic inhibition of EphA2 in NRAS and BRAF mutant melanomas. (2013) (0)
Mulling Over Mutations: NRAS-Mutated and BRAF-Mutated Melanomas Are Biologically Distinct (2011) (0)
P110 Mutational analysis of CDKN2A and CDK4 genes in a hospital-based series of Greek patients with melanoma (2010) (0)
The Bottom Line on Acral Melanoma (2009) (0)
Trimming the Hedgehog (2009) (0)
Divergent BRAF Inhibitor Resistance Mechanisms Revealed through Epigenetic Mapping. (2022) (0)
Melanoma Small molecule inhibitors of protein kinase CK 2 reduce proliferation and viability of melanoma cells in vitro (2015) (0)
Familial Atypical Mole Melanoma (FAMM) Syndrome (2010) (0)
Reply to: "The ABCDs of melanoma-A complicated morphologic message not intended for the general public". (2015) (0)
A SNP in Systemic Sclerosis (2007) (0)
Cancer Stage at Diagnosis in Transplant Recipients and Patients with HIV Infection (2015) (0)
Oncogenic Lesions in Lentigines (2009) (0)
Martin C. Mihm, Jr and the history of the Pigmented Lesion Clinic at the Massachusetts General Hospital (2010) (0)
Abstract 776: Functional analysis of BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) in melanoma. (2013) (0)
enetics for the Practicing Dermatologist (0)
Coffee and Melanoma: Buzz-Worthy (2015) (0)
Minimal Nodal Disease in SLN Melanoma Indicates Better Survival (2011) (0)
Sentinel Lymph Node Biopsies for Thin Melanomas (2014) (0)
Ulceration and Melanoma (2014) (0)
Who's Leading Who? T-Cell Density and Metastatic Risk in Skin (2016) (0)
Abstract LB-103: Molecular exploitation of oncogenic stress in melanoma management (2016) (0)
More Evidence That Two Are Better Than One (2014) (0)
Germline predisposition in oncologic and dermatologic melanoma cohorts. (2022) (0)
A Touching Mouse Tale (2009) (0)
BRAF Inhibitors and Bell Palsy (2013) (0)
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study. (2023) (0)
Sunscreen Recommendations Should Be Made Much More Often (2013) (0)
Combined Nivolumab and Ipilimumab or Monotherapy for Untreated Melanoma (2015) (0)
A Scar Is Born (2004) (0)
Patient-identified early clinical warning signs of nodular melanoma: a qualitative study (2021) (0)
Too Much Sun Is Not the Only Risk Factor at That Tiki Bar (2013) (0)
The Lethal Thin Melanoma — Wolf in Sheep’s Clothing (2007) (0)
A Genetic Marker for Stevens-Johnson Syndrome (2004) (0)
Melanoma Gets More Classy (2015) (0)
A New Message from the USPSTF (2012) (0)
A Mammoth Finding in Woolly Hair (2008) (0)
New Drug for Treatment of Advanced or Unresectable Melanoma (2014) (0)
Comedo-Genetic Agents: Sequencing of the P. Acnes Genome (2004) (0)
Genotypes for Pigmentation and Skin Cancer (2008) (0)
Malignant Transformation of Melanocytic Nevi (2012) (0)
Of Mice and Melanoma (2004) (0)
The More Things Change ... the More They Stay the Same (2013) (0)
Research to Develop and Apply Biophotonics to Military Medicine Needs (2012) (0)
Pigmentary and Blistering Keratinopathies Go Head to Head (2006) (0)
New Technologies Reveal New Melanoma Genes (2011) (0)
How Sweet It Is (2004) (0)
Iconography : Clinical spectrum of cutaneous melanoma morphology (2018) (0)
Stem Cells to the Rescue (2007) (0)
2009 Melanoma Staging: Mit's in the Skin (2010) (0)
Not All Anti-CTLA4 Antibodies Are Alike (2013) (0)
Focusing on Metastasis in Ocular Melanoma (2011) (0)
C-Reactive Protein and Melanoma Outcome (2015) (0)
Resilience of melanoma diagnostics at a tertiary-care hospital during the SARS-CoV-2 pandemic (2022) (0)
A T-Cell/Collagen IV Connection in Psoriasis (2007) (0)
Dermatology Top Stories of 2011 (2011) (0)
Blob Buster: Peptide-Induced Ablation of Adipose Tissue (2004) (0)
Iconographies supplémentaires de l'article : Guidelines of care for the management of primary cutaneous melanoma (2018) (0)
Mouse Model of Congenital Nevi (2012) (0)
PD-1: More Than Immunity in Melanoma (2015) (0)
A Mutation Signature in Sebaceous Tumors (2006) (0)
“Bottled” Tans — From Artificial to Real (2006) (0)
Welcome Our New Editors (2010) (0)
Going Mobile: Migration of Keratinocytes (2003) (0)
The Human Genetic Color Wheel (2007) (0)
A Dose of Dermis for Dementia (2004) (0)
Patching Up Squamous Cell Carcinomas (2007) (0)
Reply to: "The absence of multiple atypical nevi in germline CDKN2A mutations". (2016) (0)
Eyes: No Prize with Selumetinib (2014) (0)
A Pocket Guide to Malignant Melanoma (2001) (0)
Melanoma at Arm's Length (2015) (0)
Induced Psoriasis in Mice Suggests a Role for (2005) (0)
Hogg in the Limelight (2002) (0)
Mutation: A Genetic Basis for Polyarteritis Nodosa (2014) (0)
Cutting for Hair (2007) (0)
Clinical Genetics and Risk Assessment of Melanoma (2020) (0)
Scaling New Heights in Ichthyosis Genetics (2006) (0)
14407 The Cancer Risk Among MITF E318K Mutation Carriers (2020) (0)
A Solar Paradox (2005) (0)
Parkinson Disease and Melanoma May Share a Genetic Link (2012) (0)
Specific Genetic Risk Factors for Basal Cell Carcinoma (2008) (0)
Death by the Imiqui-MOD Squad (2003) (0)
New Insights into Melanoma Tumor Syndromes (2022) (0)
Excisional Margins in High-Risk Melanoma: The MSG Trial (2004) (0)
Topical Steroids Disturb Collagen Synthesis (2003) (0)
Hereditary Basal Cell Carcinomas Basal Cell Nevus Syndrome ( Gorlin Syndrome , Gorlin – Goltz Syndrome (2012) (0)
Cutaneous melanoma in women### The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters (2017) (0)
Melanoma and Maternity (2009) (0)
Author reply (0)
Acral Melanomas Represent a Rare but Potentially Aggressive Form of Melanoma (2013) (0)
Governance of Cutaneous Photocarcinogenesis by Chronic UVA-Exposed Dermal Fibroblasts (2014) (0)
Two Steps Forward, One Step Back in Melanoma Treatment (2005) (0)
Delays in Melanoma Surgery (2015) (0)
An Aspirin a Day Keeps the Surgeon Away (2010) (0)
FTO, BMI, and Melanoma Risk (2013) (0)
Dermatology Top Stories of 2010 (2010) (0)
How Effective Is Melanoma Screening (2011) (0)
Allergic to Cash (2003) (0)
Long-Term Outcomes and Predictors of Response with Imiquimod for Lentigo Maligna (2016) (0)
Stem Cells 101 (2008) (0)
Nivolumab for BRAF-Wildtype Tumors (2014) (0)
Abstract LB-121: ACK in BRAF inhibitor resistance (2017) (0)
Success of PD-1 Blockade as Melanoma Therapy Predicted by Evidence of Prior Immune Response (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Hensin Tsao?

Hensin Tsao is affiliated with the following schools:

Lund University
Massachusetts General Hospital
Harvard University

Hensin Tsao's Academic­Influence.com Rankings

Hensin Tsao's Degrees

Why Is Hensin Tsao Influential?

Hensin Tsao's Published Works

Published Works

What Schools Are Affiliated With Hensin Tsao?

Hensin Tsao's AcademicInfluence.com Rankings